III 118th CONGRESS 1st Session S. RES. 510 IN THE SENATE OF THE UNITED STATES December 14, 2023 Ms. Warren (for herself, Ms. Baldwin , Mr. Blumenthal , Mr. Schumer , Mr. Heinrich , Mr. Merkley , Mr. Padilla , Ms. Hirono , Mr. Brown , Mr. Hickenlooper , Ms. Stabenow , Mr. Bennet , Ms. Duckworth , Ms. Cantwell , Mrs. Shaheen , Mr. Van Hollen , Mr. King , Mr. Wyden , Mr. Fetterman , Ms. Butler , Mr. Reed , Mr. Carper , Ms. Cortez Masto , Mr. Welch , Ms. Rosen , Mr. Murphy , Ms. Sinema , Mr. Sanders , Mr. Menendez , Mrs. Gillibrand , Ms. Smith , Mr. Schatz , Mr. Kelly , Mr. Markey , Ms. Hassan , Mr. Whitehouse , Mr. Warnock , Mr. Durbin , Mr. Booker , and Ms. Klobuchar ) submitted the following resolution; which was referred to the Committee on Health, Education, Labor, and Pensions RESOLUTION Expressing the sense of the Senate that the scientific judgment of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.